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Background: Engaging individuals who have a substance use disorder (SUD) in treatment continues to be a
challenge for the specialty addiction treatment field. Research has consistently revealed high rates of missed
appointments at each step of the enrollment process: 1. between calling for services and assessment, 2. between
assessment and enrollment, and 3. between enrollment and completion of treatment. Extensive research has
examined each step of the process; however, there is limited research examining the overall attrition rate across
all steps.
Methods: A single case study of a specialty addiction treatment agency was used to examine the attrition rates
across the first three steps of the enrollment process. Attrition rates were tracked between August 1, 2011 and July
31, 2012. The cohort included 1822 unique individuals who made an initial request for addiction treatment services.
Monthly retrospective reviews of medical records, phone logs, and billing data were used to calculate attrition rates.
Attrition rates reported in the literature were collected and compared to the rates found at the target agency.
Results: Median time between request for treatment and assessment was 6 days (mean 7.5) and between
assessment and treatment enrollment was 8 days (mean 12.5). An overall attrition rate of 80% was observed,
including 45% between call and assessment, 32% between assessment and treatment enrollment (another 17%
could not be determined), and 37% left or were removed from treatment before 30 days. Women were less likely
to complete 30 days of treatment compared to men. No other demographics were related to attrition rates.
Discussion: One out of every five people who requested treatment completed a minimum of 30 days of a
treatment. The attrition rate was high, yet similar to rates noted in the literature. Limitations of the single case study
are noted.
Conclusion: Attrition rates in the U.S. are high with approximately 75% to 80% of treatment seekers disengaging at
one of the multiple stages of the enrollment and treatment process. Significant changes in the system are needed
to improve engagement rates.
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Attrition is the norm
Engaging individuals who have a substance use disor-
der (SUD) in specialty addiction treatment services has
been and continues to be a daunting challenge for treat-
ment providers. Research has consistently revealed high
rates of missed appointments; i.e., no-shows, for as-
sessments and enrollment in addiction treatment ser-
vices across all levels of care [1,2] Retaining individuals
who eventually enroll in treatment is an additional
challenge with attrition rates ranging from 40% to 60%
within days to a few weeks of initiating a treatment
episode [3-5].
Attrition rates across all stages of the engagement pro-
cess within an urban specialty addiction treatment pro-
vider are reviewed in this manuscript. We first provide
a literature review of attrition rates to determine the
average rate of withdrawal across each stage of the en-
rollment process. The review included published reports
of attrition rates across each stage of the engagement
process as well as the average delay in days between
each stage of the enrollment process. These data bench-
marks are used to compare the result of our agency
data.
The challenge of engaging people with a substance use
disorder
Individuals who seek addiction treatment services repre-
sent a small percentage of Americans who have a SUD.
SAMHSA [6] estimated that 23 million Americans in
2012 needed some type of intervention to reduce or stop
their substance abuse patterns; however, only 16% (3.6
million) of these individuals self-reported a need for
treatment. Within the 3.6 million Americans who repor-
ted a need for treatment, 69% (2.5 million) received treat-
ment in the past year and the other 31% (1.1 million) did
not. Of the 1.1 million who identified a need, but did not
receive treatment, 31% (3.41 thousand) attempted to ac-
cess treatment and the other 69% (7.59 thousand) did not
make an attempt.
Individuals who have identified a need for treatment
are more likely to be experiencing significant consequen-
ces and functional impairments as a result of their drin-
king or drug use patterns compared to those who have
not identified a need for help [7-9]. Individuals who seek
addiction treatment are more likely to be male (67% male)
[10,11], unemployed or no longer in the labor force (78%)
[12,13], involved in the criminal justice system (34% to
50%) [12-14] and have had a prior treatment episode
(59%) [12] compared to individuals with similar sub-
stance abuse patterns who don’t seek addiction treat-
ment services. Individuals who engage in treatment for
the first time have been using alcohol or other drugs
for 15 to 17 years, on average [15,16].Multiple stages of treatment engagement
Entering a State-funded addiction treatment program in-
volves a three stage process: 1. Initial request for services
(IRS) that usually occurs through a phone call, 2. attend-
ing and completing the assessment appointment, and
3. being referred to and in enrolling in a treatment pro-
gram. Completing a treatment episode can be consid-
ered a fourth stage. Research has revealed significant
attrition at each stage of the process.
Tables 1 and 2 include a summary of published research
on the first three stages of the enrollment process. We
focused the literature review on evaluations of specialty
addiction treatment services reflective of the agency in-
volved in the pilot study described in the method section
of this manuscript. Specifically, the review on attrition
included:
 research that focused on engaging clients in a
treatment program, such as outpatient, residential,
or methadone maintenance (studies that examined
transitioning clients from one treatment episode to
another, were excluded),
 specialty addiction treatment services, such as non-
profit, for-profit, private, public and government-
based services (programs housed solely in mental
health, medical, university or web-based settings
were excluded),
 publications after 1989,
 conducted in the United States only, and
 treatment populations for adults, 18 years and older.
The cutoff of 1990 was selected to include treatment
programs that are more likely to reflect specialty treat-
ment programs in 2011 and 2012. Research included nat-
uralistic studies, such as archival data analyses of attrition
rates, pre-post interventions designed to improve show
rates, and secondary analyses of randomized clinical trials
in residential or outpatient settings that examined attrition
rates.
Table 1 includes research that examined attrition rates
between IRS and assessment, between assessment and
enrollment in treatment, or both. The Table includes the
manuscript citation, the number of agencies involved in
the analyses, the enrollment stage; ie., after IRS or as-
sessment, the number of unique clients tracked in the
study, and the percentages of clients who showed and
did not show for the assessment appointment or treat-
ment enrollment date. Several studies collected data from
centralized intake facilities that referred clients to multiple
agencies in a countywide area. The count of “multiple” is
used for publications that did not report the actual num-
ber of agencies that received clients from a central-
ized intake program. Weighted and un-weighted mean
show/no-show rates are provided for each stage of the
Table 1 Show rates for clients after IRS or assessment
Authors & date # of agencies Enrollment stage Sample size Showed% No-showed%
Longhi et al., 1991 [17] Multiple IRS 1567 71% 29%
Fehr et al., 1992 [1] 1 IRS 505 37% 63%
Festinger et al., 1995 [18] 1 IRS 235 42% 58%
Sequeland et al., 2002* [2] 4 IRS 1777 53% 47%
Chawdhary et al., 2007* [19] 1 IRS 883 42% 58%
IRS weighted mean 54% 46%
IRS un-weighted mean 49% 51%
Longhi et al., 1991 [17] Multiple Assessment 909 66% 34%
Kleinman et al., 1992* [20] 1 Assessment 148 58% 42%
Gottheil et al., 1994 [21] 1 Assessment 634 80% 20%
Ershoff et al., 1996 [22] 8 Assessment 1986 80% 20%
Rohrer et al., 1996 [23] Multiple Assessment 17,874 45% 55%
Vendetti et al., 1997* [24] 3 Assessment 813 55% 45%
Hser et al., 1998 [25] Multiple Assessment 276 62% 38%
Pena et al., 1999* [26] 1 Assessment 294 82% 18%
Weisner et al., 2001 [27] 1 Assessment 1204 76% 24%
Arfken et al., 2001 [28] 1 Assessment 2471 82% 18%
Donovan et al., 2001* [29] Multiple Assessment 654 71% 29%
Claus & Kindleberger, 2002 [30] 1 Assessment 260 75% 25%
Parker et al., 2002 [31] 1 Assessment 127 49% 51%
Angarita et al., 2007*! [32] Multiple Assessment 372 56% 44%
Pinto et al., 2011* [33] 7 Assessment 286 70% 30%
Resko & Mendoza, 2012* [34] 7 Assessment 340 82% 18%
Molfenter, 2013+ [35] 67 Assessment ? 63% 37%
Pena et al., 1999 (lit review) [26] 22 studies Assessment ? 73% 27%
Assessment weighted mean 56% 44%
Assessment un-weighted mean 67% 33%
*= randomized clinical trial – secondary analysis; ! = individuals who were accurately matched to treatment were included; + = no show rates were based on
enrollment in an outpatient program, but it was unclear if the rate was from IRS or assessment.
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order based on publication year within the two categories
of IRS and assessment. Pena et al.’s [26] literature review
of show rates after assessment is listed at the bottom of
the Table, but excluded from the calculation of show/no-
show rates. Molfenter [35] did not provide a sample size,
so the study was included only in the un-weighted mean
estimation.
Table 2 includes published studies that reported early
withdrawal rates from either residential or outpatient
treatment programs. Two methods were used in the re-
search to measure the 30-day threshold or early with-
drawal from treatment for the studies listed in Table 2.
Five studies used a specific count of 30 days as the bench-
mark for early withdrawal. The other eight studies used a
specific number of sessions attended as the benchmark
for withdrawal before 30 days, with a range of 2 to 5
sessions. The two methods of calculating withdrawal ratesare noted under the column “outcome”. Studies are listed
in ascending order based on the publication year. Carol’s
[3] literature review of retention rates is listed at the
bottom of the Table, but excluded from the calculation of
show/no-show rates. Garnick et al.’s [13] analysis of 4 state
databases of publicly-funded programs and 106,662 clients
was also excluded from the calculation of the weighted
mean.
Attrition rates across all four stages are summarized in
Table 3 based on data from Tables 1, 2 and SAMHSA’s
Treatment Episode Data Set (TEDS) for 2010 [40]. Five
published studies noted in Tables 1 and 2 that assessed
attrition across two or more stages are listed in Table 4.
Longhi et al., [17] was the only study we could locate
that included an analysis of all four stages (stages 3 & 4
were combined) based on adults calling into a county-
wide centralized intake program in Seattle, Washington.
Arfken et al., [28] tracked clients through stages 2 – 4.
Table 2 Retention rates for clients enrolled in treatment
Authors & date # of sites Treatment model Sample size Outcome Retained Withdrew early
Kleinman et al., 1992 ! [20] 1 Outpatient 86 Retained past 5 sessions 42% 58%
Ershoff et al., 1996 [22] 8 Outpatient 1587 In tx past 30 days 63% 37%
Arfken et al., 2001 [28] multiple Residential & outpatient 2026 In tx past 30 days 87% 13%
Claus & Kindleberger, 2002 [30] 1 Residential & outpatient 195 Retained past 2 sessions 80% 20%
Brown et al., 2008 pre NIATx year [36] 1 Residential 279 Retained past 3 sessions 63% 37%
Brown et al., 2008 post NIATx year [36] 1 Residential 674 Retained past 3 sessions 70% 30%
Curran et al., 2007 [4] > 10 Outpatient 9,933 Retained past 5 sessions 73% 27%
Ghee et al., 2009 [37] 1 Outpatient 104 In tx past 30 days 46% 54%
Adams et al., 2011 [38] 1 Residential 105 In tx past 30 days 77% 23%
Pinto et al., 2011 [33] 6 Outpatient 346 Retained past 5 sessions 83% 17%
McHugh et al., 2013 [39] 1 Methadone Maintenance 78 Retained past 11 sessions 77% 23%
Choi et al., 2013 [40] 3 Residential 1,317 In tx past 30 days 44% 56%
Garnick et al., 2014 [13] 783 Residential & Outpatient 106,662 Retained past 3 sessions 74% 26%
Carroll, 1997 (literature review) [3] 24 studies Outpatient >4,000 56% 44%
30-day retention weighted average without Garnick [13] 71% 29%
30-day retention un-weighted average 68% 32%
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ges 2 and 3, but did not report the number of clients
who completed treatment. The percentages displayed in
the cells reflect the number of clients from the baseline
count that were still in the engagement process after
each stage.
Published research on attrition over the past the 24
years has revealed consistent patterns of disengagement
as clients were processed through the enrollment steps.
Approximately 50% of individuals who made an IRS dis-
engaged before attending an assessment. Approximately
40% of treatment seekers disengaged after completing
an assessment and before entering a treatment program.
Finally, 30% of all clients who entered an addiction treat-
ment program withdrew or were removed from treat-
ment within 30 days, another 11% to 14% left after 30
days, and an additional 12% to 15% were transferred to
a different level of care before completing treatment.
Completion rates were higher in residential-based pro-
grams and lower for outpatient services. Two studies
that tracked a cohort of clients across multiple stages of
the engagement process found significant attrition ran-
ging from 60% to 72% between initial engagement and
the completion of a single treatment episode.Table 3 Summary of attrition rates at each stage of engagem
Weighted mean percentage Un-w
IRS attrition 46%
After assessment attrition 44%
30-day tx attrition 29%
Treatment incomplete SAMHSA [12] 56%Extensive delays between IRS and treatment
Time, as measured in days between each stage of the
enrollment process, has been identified as a significant
factor of attrition from addiction treatment [5]. Carr and
colleagues [41] found that multiple individual, agency
and system-level factors contributed to increased wait
times between IRS, assessment and treatment enrollment.
Attrition as a function of time occurs in two stages: a
rapid increase within the first 24 to 48 hours after the IRS,
followed by an incremental increase based on each add-
itional day added to the wait time [1,5,18].
Individuals who received same day access to an assess-
ment or treatment after making an IRS were significantly
more likely to show for their appointment. Five random-
ized experiments that tested the relationship between
wait time and show rates in addiction treatment pro-
grams are listed in Table 5. Individuals who made an IRS
were randomly assigned to an assessment appointment
within 24 hours (same day or by the next day) or to a spe-
cific number of days, such as 2, 4 or 7. The average wait in
the control condition was 3 to 4 days in four of the five
studies.
Individuals who had same-day access to the assess-
ment after making an IRS were two and half times moreent and treatment
eighted mean percentage Range Other literature reviews
51% 29% to 63%
33% 18% to 55% Pena et al.,1999 [26] –27%
32% 13% to 58% Carroll, 1997 [3] – 44%
NA 33% to 86%
Table 4 Retention rates across four stages of engagement & treatment
Authors & date Sample size IRS Assessment Retained Treatment complete
Longi et al., 1991 [17] 1567 1118 (71%) 600 (44%)* 386 (28%)
Arfken et al., 2001 [28] 2471 2026 (82%) 1766 (71%) 989 (40%)
Claus & Kindleberger, 2002 [30] 260 195 (75%) 156 (60%)
Kleinman et al., 1992 [20] 148 86 (58%) 36 (24%)
Pinto et al., 2011 [33] 346 286 (83%) 201 (58%)
*= 209 individuals were ineligible for services after assessment, which lowered the base sample to 1358.
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assigned an appointment that was 3 to 7 days from the
IRS. The odds ratio would have been larger if resear-
chers had extended the wait time in the control condi-
tion beyond seven days, as was shown in the Maddox
and Desmond [46] study. Several pre-post or naturalistic
studies found similar results [1,17,18,30,47].
Table 6 includes 12 studies that reported an average
number of days between IRS and assessment, between
assessment and enrollment in treatment, or both. Publi-
cations included six listed in Tables 1, 2, 3 as well as six
additional studies that specifically examined waiting
times or wait lists in specialty addiction treatment pro-
grams. Articles are organized by IRS or assessment stages
and listed in ascending order by publication year.
The average wait time between IRS and assessment was
8 to 9 days (range 4 to 21 days) and the average wait time
between assessment and treatment enrollment was 6 to
11 days (range 3 to 24). Wait time for residential treat-
ment was usually longer than outpatient services, when
both levels of care were assessed within the same study.
There is an extensive body of literature on attrition
rates at each step of the enrollment process; however, we
located only two publications in the past 25 years that
tracked a cohort of treatment seekers over three or four
steps or stages of the enrollment process. Cross sectional
data and limited longitudinal data indicated extensive at-
trition of treatment seekers who make an IRS. The pur-
pose of this study was to track a cohort of clients across
the first three stages of the enrollment process to deter-
mine the true attrition rates when all steps are included.Table 5 Randomized clinical trials testing same-day access pr
Authors & date Sample size Same day (0 & 1) s
Stark et al. 1990 [42] 38 exp, 22 tau 55% (21)
Festinger et al. 1996 [43] 39 exp, 39 tau 59% (23)
Festinger et al., 2002 [44] 58 exp, 58 tau 64% (37)
Stasiewicz & Stalker, 1999 [45] 32 exp, 96 tau 72% (23)
Maddox & Desmond 1995* [46] 93 exp, 93 tau 96% (89)
Average 69%
Exp = Subjects assigned to same-day or within 24 hours, tau = Treatment as usual_s
maintenance program-14 days for tau.Case study of a specialty behavioral health agency
The attrition rates of a large, specialty addiction treatment
provider were examined and compared to rates collec-
ted from our literature review. Retrospective medical
records data were used from the target agency to exa-
mine the attrition rate of individuals seeking addiction
treatment. Tracking of clients was initiated on August
1, 2011 when the target agency expanded outpatient
services and closed one of its three long-term residen-
tial programs. Prior to the change on August 1, 2011,
the agency provided outpatient services to men and
women who were in either criminal justice-based pro-
grams or medication-assisted services, but had no general
outpatient services for voluntary clients who were not in
need of either a residential level of care or medication-
assisted treatment. Starting on August 1, 2011, the agency
expanded outpatient addiction treatment services by
adding approximately 100 additional treatment slots
for men and women who were not involved in the
criminal justice system while maintaining the other
outpatient services. The new outpatient model was
based on a cognitive behavioral therapy format [52].
The agency also closed a long-term residential pro-
gram for women (24 beds), leaving two remaining resi-
dential programs, one for men (32 beds) and one for
women (28 beds). All residential programs were 60 to
90 days in duration.
Identifying the overall attrition rate was the primary
purpose of tracking all individuals who requested treat-
ment at the target agency for 12 consecutive months,
beginning on August 1, 2011.otocols







ubjects assigned to appointments beyond 24 hours, *= methadone
Table 6 Average days between IRS & assessment and assessment & treatment
Authors & date # of agencies Sample size Tx type Stage of enrollment Average # of days
Longhi et al., 1991 [17] Multiple 1567 Residential & Outpatient IRS 21
McCarty et al., 2007* [48] 13 6016 Residential & Outpatient IRS 5
Carr et al., 2008 [41] Multiple 577 Outpatient IRS 4.4
Brucker & Stewart, 2011 [49] Multiple 6629 Outpatient IRS 8.1
Brucker & Stewart, 2011 [49] Multiple 2457 Intensive Outpatient IRS 7.9
Quanbeck et al., 2013 [50] 192 NA Residential & Outpatient IRS 7.2
Weighted average # of days between IRS & assessment 8.0
Un-weighted average # of days between IRS & assessment 8.9
Hoffman et al., 2011 [5] 15 4937 Residential & Outpatient Assessment 8.3
Donovan et al., 2001 [29] Multiple 654 Residential Assessment 24.2
Outpatient Assessment 9.9
Arfken et al., 2001 [28] Multiple 2026 Residential & Outpatient Assessment 9.1
Claus & Kindleberger, 2002 [30] 1 260 Residential & Outpatient Assessment 4.2
Downey et al., 2003 – women only [47] Multiple 206 Residential & Outpatient Assessment 29
Downey et al., 2003 – men only [47] Multiple 448 Residential & Outpatient Assessment 16
Chawdhary et al., 2007 [19] 1 883 Outpatient Assessment 6.2
McCarty et al., 2007* [48] 13 6016 Residential & Outpatient Assessment 10
Brucker & Stewart, 2011 [49] Multiple 6629 Outpatient Assessment 4.9
Brucker & Stewart, 2011 [49] Multiple 2457 Intensive Outpatient Assessment 3.9
Guerrero, 2013 [51] 104 13,329 Residential & Outpatient Assessment 3.4
Weighted average # of days between assessment & treatment enrollment 6.4
Un-weighted average # of days between assessment & treatment enrollment 10.8
NA = Not applicable, sudy did not track people, but rather tested the wait time after IRS by making calls to 192 agencies; *= baseline data before NIATx
changes occurred.
Loveland and Driscoll Substance Abuse Treatment, Prevention, and Policy 2014, 9:41 Page 6 of 13
http://www.substanceabusepolicy.com/content/9/1/41Methods
Target agency
The agency, heretofore referred to as Urban Addiction
Treatment (UAT), is nested within a city of 120,000, a
county of 190,000, and a three-county area of 350,000
residents in Illinois. Racial mix of the city includes 73%
White, 20% African American, and 4% to 6% Hispanic
populations. Demographic indicators of the city highlight
a population that has a significantly high poverty rate,
compared to the State average, along with other com-
monly linked conditions associated with high poverty;
e.g., high rates of infant mortality, crime, addiction, HIV/
Hepatitis, and other medical conditions.
UAT is classified as a 501c-3, private, nonprofit, spe-
cialty behavioral health organization that provides a
range of treatment interventions on an annual budget of
approximately $16.5 million dollars in the 2011–2012
fiscal year. UAT provided a range of addiction treatment
services to 2,000 to 3,000 individuals annually in years
2011 and 2012, which included:
 a 12-bed medical detoxification program,
 gender specific residential programs, intensive (IOP) and low-intensive outpatient (OP)
services,
 medication assisted treatment (methadone &
suboxone),
 treatment services for clients enrolled in a two
problem-solving court programs: one for drug court
and one for mental health court,
 State-licensed DUI assessment and treatment
services,
 ancillary services (e.g., psychiatric consultation,
HIV testing, transportation services), and an
outpatient program that serves clients from
Employment Assistance Programs (EAPs) and
private insurance.
UAT is also the County’s community mental health
center, serving approximately 1,000 adults with a serious
mental illness annually. UAT is a safety-net organization
in terms of the target population. Individuals who re-
ceive UAT services were and still are highly likely to be
unemployed, involved in the criminal justice system, re-
ceiving public assistance in the form of Medicaid and
social security disability benefits (or indigent), and have
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in the State.
UAT’s service profile was unique during the cohort
tracking period in several aspects compared to other spe-
cialty addiction treatment providers in the State as re-
vealed in SAMHSA’s National Survey on Substance Abuse
Treatment Services [40,53]. Unique or uncommon aspects
of UAT’s service profile included:
 free standing medical detoxification unit,
 active daily census of over 200 clients and larger
caseloads in detoxification and residential treatment
than national averages,
 two long-term residential programs (60 to 90 days),
 a comprehensive range of mental health services for
people with serious mental illness,
 Joint Commission Accreditation (most specialty
addiction treatment agencies in the U.S. are
accredited by CARF),
 Onsite primary care clinic operated by a Federally
Qualified Health Clinic, and
 medication assisted treatment for methadone and
suboxone.
The catchment area of addiction treatment services in-
cludes the entire State of Illinois. Between 40% and 60%
of clients enrolled in the residential programs resided
outside of the primary county where UAT is located.
The outpatient programs tended to serve individuals liv-
ing within a three county area.
UAT’s funding structure is similar to most non-profit
specialty behavioral health programs in the U.S. in that
it relies on State general revenues, federal block grant
dollars, and Medicaid to finance services [30,37]. The
Division of Alcohol and Substance Abuse (DASA), within
the Illinois Department of Human Services (IL-DHS), is
the primary customer of UAT’s addiction treatment ser-
vices and provide approximately 90% of UAT’s revenues
for addiction treatment services. DASA provides funding
to UAT through an annual capped contract. DASA dollars
include a combination of state general revenues and fed-
eral block grant dollars. UAT can also bill Medicaid or pri-
vate insurance, in place of DASA funds, for those clients
who have insurance. DASA contract dollars and State Me-
dicaid are earned through a fee-for-service billing process.
UAT developed a centralized intake process to manage
the large flow of individuals seeking mental health or
addiction treatment services. The benefit of this process
was instituting a uniformed assessment that reduced data
collection errors while meeting the unique requirements
of DASA, the Division of Mental Health (DMH), and the
Joint Commission. The downside of the centralized pro-
cess was an expanded paperwork protocol that added sur-
vey questions and time to the assessment. Individuals hadto complete an assessment process that required one to
two hours of their time before an appointment for treat-
ment could be established.
Procedures
Individuals were included in the cohort if they had
 an IRS through UAT’s central intake program
between August 1, 2011 and July 30, 2012,
 requested addiction treatment services during their
IRS,
 agreed to be scheduled for an assessment (phone or
in person), and
 were 18 years or older.
The cohort was identified through a review of medical
records and an in-house database program that stored
information on all IRS calls. A 30-day timeframe was
used within each stage of the enrollment process to cate-
gorize individuals in the cohort based on their referent
request for treatment. IL-DHS/DASA established a 30-
day window for adults enrolled in an outpatient program
[54]. The outpatient addiction treatment episode was
terminated if an individual did not receive a billable con-
tact within 30 days. For consistency, we used the same
30-day period to categorize individuals who requested
treatment and were waiting for an assessment as well as
for those who completed the assessment and were wait-
ing to enter a treatment program.
Measurement
Show/no-show rates were tracked through the first three
stages of the enrollment process. Measurement of each
stage included:
Initial request for services (IRS) attrition rate
Individuals who received an assessment within 30 days
of the referent IRS were classified as attending/showing
for their appointment and counted once, even if they
had scheduled and missed several appointments between
the request and completing the assessment. Individuals
who did not attend the assessment appointment within
30 days were classified as missing the assessment once,
even though many of these individuals scheduled and
missed two or more appointments in 30 days. Between
30% and 50% of all assessment appointments were re-
scheduled based on individuals missing their appoint-
ments (not calling in advance) or calling and rescheduling.
Assessment attrition
Individuals classified as attending/showing for their as-
sessment were tracked for up to 30 days from the date of
their assessment. Individuals were classified as either at-
tending/showing for treatment enrollment or no-showing









Gender 1003 577 362
Male 522 (52%) 310(54%) 206(57%)
Female 481 (48%) 267(46%) 156(43%)*
Race
White 739 (74%) 451 (78%) 283 (78%)
Black 185 (18%) 114 (20%) 74 (20%)
Other 24 (2%) 12 (2%) 5 (1%)
Unknown 55 (5%) 0 (0%) 0 (0%)
Age
Average Age 34 34 35
Treatment history
Prior treatment 587 (59%) 371 (64%) 235 (65%)
No prior treatment 327 (33%) 199 (34%) 123 (34%)
Unknown treatment history 89 (9%) 7 (1%) 4 (1%)
On probation or parole
Criminal justice involvement 386 (38%) 253 (44%) 167 (46%)
No criminal justice
involvement
538 (54%) 318 (55%) 191 (53%)
Unknown criminal justice
status
78 (8%) 5 (1%) 4 (1%)
Open case with DCFS
Involved with department
of children & family
services (DCFS)
104 (10%) 54 (9%) 32 (9%)
No CFS involvement 812 (81%) 517 (90%) 326 (90%)
Unknown CFS status 87 (9%) 6 (1%) 4 (1%)
*= Odds Ratio of .83 (CI 95%, .6 to .96).
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Billing data were used to determine if a person showed for
treatment.
30-day treatment attrition
Individuals who enrolled in treatment were tracked for
30 days from the treatment enrollment date. Two pro-
tocols were used to measure attendance/attrition over
30 days based on level of care. Individuals enrolled in re-
sidential treatment, excluding detoxification, were classi-
fied as actively engaged in treatment if they received 30
continuous days of treatment and were actively enrolled
on the 30th day, based on billing records. All individuals
who were discharged prior to the 30th day were classified
as early withdrawal. NIATx guidelines were used to mea-
sure attrition in outpatient services [48]. Individuals who
enrolled in the outpatient program were classified as at-
tending treatment if they received four treatment epi-
sodes, delivered on four separate days, within 30 days
of the treatment enrollment date. A treatment episode
included either individual or group counseling session
(nearly all contacts were group sessions). Individuals who
received three or fewer billed events within 30 days of be-
ing enrolled in the program were classified as early with-
drawal, even if they received a billable contact beyond
30 days (e.g., reengaged before being closed).
Addiction treatment services tracked
All UAT addiction treatment services were included
in the tracking process, such as residential treatment,
medication-assessed OP, court-based services, or the
newly formed OP program. Individuals seeking only
detoxification or needing to complete a State-licensed
DUI-specific assessment and education program with-
out requiring additional treatment options were ex-
cluded from the cohort.
Demographic data collected
Demographic data were not available for most of the in-
dividuals who made an IRS, but did not show for the as-
sessment; so only the count of IRS’ made was included
in the first stage of the enrollment process. Demographic
data were collected on all individuals who completed the
assessment and pulled from UAT’s electronic health rec-
ord or chart reviews. Age, gender, and race were consist-
ently reported (entered) in the medical record and were
used in the analyses. Other demographics, such as in-
come, employment status, or marriage status were in-
consistently reported and were excluded from analyses.
Treatment history and involvement in the criminal
justice system were pulled from chart reviews of the
assessment form. History of addiction treatment was
converted into a dichotomous variable of 1 for any
prior addiction treatment or 0 for none noted in theassessment form. Criminal justice involvement was grouped
into three categories: 1. No involvement noted in the as-
sessment form, 2. on probation or parole, or 3. involved in
Department of Child and Family Services (DCFS).
A research associate pulled data monthly from an
agency database that stored the names and contact in-
formation of all individuals who called UAT requesting
treatment. Contact data were reviewed with the intake
staff on a monthly basis to verify information. Billing
data were pulled from the agency’s electronic health rec-
ord system that included both service and billing data.
The University of Illinois College of Medicine at Peoria’s
Institutional Review Board provided approval for the
retrospective chart review protocol.
Results
Descriptive analyses
The total cohort included 1822 individuals who made an
IRS and were given an assessment appointment. Table 7
Loveland and Driscoll Substance Abuse Treatment, Prevention, and Policy 2014, 9:41 Page 9 of 13
http://www.substanceabusepolicy.com/content/9/1/41displays the demographic data of 1003 clients who com-
pleted the assessment. The cohort was mostly White
(78%), more likely to have had one or more prior treat-
ment episodes (64%), slightly less likely to be involved in
the criminal justice system (44%), nearly split between
men and women (52/48), and averaged 34 years old. De-
mographic data are displayed across the assessment, treat-
ment enrollment, and 30-day treatment retention stages.
An odds ratio of completing 30 days of treatment was cal-
culated for each demographic variable noted in the Table.
Women were less likely to complete 30 days of treatment
compared to men (OR = .73; CI 95% .60 to .86). There
were no other significant or differential attrition rates
found for prior treatment experience, age, race, or involve-
ment in the criminal justice system.
The overall attrition rates by each enrollment stage are
displayed in Figure 1. Forty-five percent of individuals
who received an IRS did not show for the assessment
appointment. Thirty-two percent of individuals who com-
pleted the assessment and were referred to treatment did
not enroll in a treatment program and another 17% were
not referred or the referral destination could not be deter-
mined. Thirty-seven percent of individuals who enrolled
in treatment withdrew before completing 30 days of treat-
ment. Overall, 80% of the cohort disengaged from the en-
rollment process before completing 30 days of treatment.
For clients who showed for the assessment or enrolled
for treatment, the median time between IRS and assess-
ment was 6 days (mean 7.5) and the median time bet-
ween assessment and treatment enrollment was 8 days
(mean 12.5). Treatment enrollment appointments were
not established for clients referred to residential treat-
















IRS=initial request for services; OP=outpatient; Res
Figure 1 Attrition rates by level of care and stages of enrollment.we were unable to determine the median time between
those who showed and did not show for treatment.
Table 8 includes data on the outcomes of clients based
on the initial referral to treatment; i.e., OP or residential.
Seventeen percent (170) of the clients assessed were either
not referred to treatment for a variety of reasons (97; e.g.,
waiting for court hearing or not wanting additional ser-
vices), referred out (28) or unknown (45). However, 11 of
these individuals eventually arrived at a treatment pro-
gram as noted in the Table and were included in all ana-
lyses. For clients who enrolled in treatment, 97% of those
referred to OP arrived at OP (3% switched to residential)
and 87% of those referred to residential arrived at residen-
tial (13% switched to OP). Sixty-three percent (362) of all
clients who enrolled in treatment remained in treatment
for 30 days with similar rates of retention between OP
(4 or more billable contacts within 30 days) and residential
levels of care.
We completed a prospective review of UAT’s billing
records up to June 30, 2014 for the 1003 clients who
had completed an assessment during the cohort tracking
period and found that:
 233 (23%) had at least one more IRS during the
12-month tracking period,
 286 (29%) had an IRS and assessment completed
over the following two years,
 249 (25%) received one or more UAT addiction
treatment episodes after the referent treatment
episode in the cohort, and
 145 (14%) enrolled in UAT’s detoxification program









Table 8 Client outcomes based on residential or outpatient referral
Referral at assessment Total referred (%) Did not show for tx or not referred (%) Showed for residential (%) Showed for OP (%)
Residential 446 (44%) 131 (31%) 273 (96%) 42 (14%)
OP 387 (39%) 136 (32%) 8 (3%) 243 (83%)
Not referred or unknown 170 (17%) 159 (37%) 2 (1%) 9 (3%)
Total 1003 (100%) 426 (100%) 283 (100%) 294 (100%)
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rates with the averages noted in Tables 3, 4, 6 and 9.
Longi et al.’s [17] results are included in the last column.
We calculated an estimated number of clients who
would still be in treatment at 30 days based on the aver-
age attrition rates listed in each column, with all four
columns starting at 1822 clients. UAT’s final count based
on actual clients is lower; i.e., higher attrition, than the
estimated counts listed in the other three columns due
to UAT’s higher attrition rate during treatment. UAT’s
attrition estimate may also be higher due to the unknown
outcome of 170 individuals who were assessed, but a refer-
ral was not made or could not be determined. UAT had a
similar mean wait time between IRS and assessment, but a
longer mean wait time after assessment and before treat-
ment enrollment compared to the averages derived from
the literature review.
Discussion
The use of a single case study provided an opportunity
to examine the overall attrition rates for individuals
seeking addiction treatment over a period of 12 months.
However, UAT’s attrition rates are based on one agency
and may not be indicative of approximately 355 non-
profit, 257 for-profit or 26 government-based organiza-
tions providing addiction treatment services in Illinois
[53]. Another limitation of the study is that attrition rates
and demographic data were based on retrospective chart,
contact and billing data rather than on prospective track-
ing of individuals. Medical charts, electronic records and
billing records are prone to entry errors and omissions.
Establishing a referent appointment date after the IRS was
particularly challenging. Individuals frequently cancelled
and rescheduled appointments before the assessmentTable 9 Comparison of UAT’s attrition rates with published re
Stage of assessment UAT
IRS to assessment 45%
Assessment to treatment 32% + 17%
Treatment enrollment to 30 days retention 37%
Total count remaining at 30-days in treatment 362
Mean wait time IRS to Assessment in days 7.5
Mean wait time assessment to treatment enrollment in days 12.5
*= completed treatment, could be a high estimation for 30-day attrition; ! = extrapooccurred. We encountered numerous data entry errors as
a result of the rescheduling process; therefore, we aban-
doned the task of collecting scheduled appointment dates
and selected the actual date of the assessment, once it oc-
curred and was billed to the State funder. Classifying indi-
viduals who were not referred to treatment was another
dilemma. We identified 170 individuals (17% of those who
completed the assessment) who did not receive a clear
referral to a UAT addiction treatment program; however,
11 of these individuals eventually enrolled in treatment
during the 30-day window of tracking. Moreover, the
assessment staff frequently noted in writing that these
no-referral clients were waiting for a court hearing be-
fore deciding if they would proceed to treatment. In
other words, many of these individuals were not ready
to enroll in treatment, but were keeping their options
open in case they were court ordered to treatment. Fi-
nally, the attrition rate for clients in outpatient services
was slightly inflated due to our benchmark of four bill-
able events within 30 days based on NIATx guidelines.
Some of the clients who received three or fewer billable
events within the 30-day timeframe received additional
services beyond 30 days.
With these limitations noted, UAT’s rates of attrition
were similar to those found in the literature after the
IRS (UAT 45%, literature 29% to 51%), after the assess-
ment (UAT 32% to 49%, literature 33% to 44%) and some-
what higher for the first 30 days of treatment (UAT 37%,
literature 29% to 36%). The waiting time between IRS and
assessment was also similar to the rate found in the litera-
ture review (UAT 7.5, literature 8.0 to 8.9); whereas the
waiting time between assessment and treatment enroll-
ment was slightly higher than the average found in the
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average of treatment seekers in age (34, national aver-
age = 34), percentage of clients with prior treatment
experience (64%, national average = 59%), and percent-
age of clients involved in the criminal justice system
(44%, national average = 30% to 50%). UAT’s popula-
tion had a higher percentage of women (48%, national
average = 33%) and a higher percentage of White, non-
Hispanic clients (78%, national average = 60%) seeking
treatment services [40].
A substantial amount of UAT resources and State
dollars were used to engage clients with limited success.
Many of the clients cancelled and rescheduled appoint-
ments, which extended the waiting time between enroll-
ment steps. UAT engagement staff were flexible and
accommodating of clients; however, each rescheduled
appointment filled up another assessment slot of one to
two hours as well as around 10 minutes of phone time
to acquire information (e.g., insurance status, involve-
ment in criminal justice, appointment time, & providing
directions to the facility). It was common to see several
hours of staff time dedicated to completing one client
assessment, if no-shows and phone time were included
in the calculation.
Treatment shopping for residential services was a tech-
nique used by some clients trying to enter a State-funded
program. Clients had to wait two or more weeks after
their assessment before knowing when they would enter
a UAT residential treatment program. The process of
waiting for a residential enrollment date was and still is
the common practice for State-funded treatment pro-
grams in Illinois. Clients would complete an assessment
at two or more agencies, without revealing the informa-
tion to UAT staff, in the hope of gaining an earlier entry
date at one of the facilities. Provider shopping added
names to wait lists across multiple agencies and re-
dundant assessments, while decreasing the likelihood
that a client would enroll in a UAT residential treatment
program.
Further, 37% of clients left treatment incomplete with-
in 30 days of enrolling, with similar rates observed in
residential and outpatient services. One out of every four
clients in the cohort returned to the UAT engagement
process within 12 months of their referent contact, seek-
ing additional treatment services. Each new episode
required the completion of all three enrollment steps.
Nearly two thirds of the cohort had received one or
more prior treatment episodes at UAT or other agen-
cies, but none of the 1822 clients were involved in a
continuum of care when they contacted UAT during
the cohort tracking period.
Our study confirmed that most individuals drop out
of the enrollment process before receiving a sufficient
dosage of addiction treatment. The next step is to developinterventions that improve the engagement process
through the front door as well as the back door as
clients’ transition through various levels of care. Mul-
tiple research studies have shown that people provided
with same-day access for an assessment are two to three
times more likely to show for their appointment com-
pared to people given an appointment within three days
of their IRS. It is not surprising to see attrition rates
around 50% between IRS and assessment when the aver-
age wait is 7 to 9 days in most addiction treatment agen-
cies, including UAT. However, there is limited research
on how to effectively triage clients who show for same-
day assessments. UAT had the staff resources to provide
same-day assessments, but lacked the capacity to pro-
vide treatment on demand to a larger pool of clients
resulting from the same-day assessment process. More-
over, there is limited research on how to engage people
who are not ready for the limited menu of treatment
options provided by the specialty addiction treatment
system.
Conclusion
Engaging and effectively treating individuals with a sub-
stance use disorder remains a challenge in the specialty
addiction treatment field. One out of five individuals
who contacted UAT for addiction treatment services re-
ceived a minimum of 30 days of residential or outpatient
services. The overall attrition rate of 80% was high, but
within the range found in the literature (75% - 79%). Li-
mited treatment slots at UAT were the primary reason
why people had to wait three weeks, on average, before
receiving treatment services. Nonetheless, it is unclear if
people disengaged because of an increased ability to ma-
nage their SUD on their own, low readiness for treat-
ment, the long wait for treatment, dissatisfaction with the
treatment options, complications associated with their ad-
diction that occurred during the wait, or an interaction of
these factors over time. The Accountable Care Act (ACA)
will increase the number of people who have insurance
for behavioral health services, which in turn could in-
crease addiction treatment slots [55-57]. Increased fund-
ing is essential, but may not be sufficient to resolve all the
factors associated with the high attrition from treatment
at UAT and most specialty addiction treatment providers
in the U.S. Capoccia and colleagues [58] found that in-
creased funding in Massachusetts failed to increase the
number of people who received addiction treatment ser-
vices, even though providers received more dollars per cli-
ent. The disconnected cycle of treatments may not change
until addiction treatment services are organized in to a
continuum of care or weaved in to a healthcare system.
Moreover, the redundancies observed in our cohort, such
as requiring clients to complete an IRS and assessment
with each return visit, will continue to disrupt the flow of
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treatment providers in the State will likely follow these
same treatment protocols/funding guidelines with the
expanded population of adults who will have Medicaid
under the ACA. Organizational and policy changes are
needed, in addition to increased funding, to make a sig-
nificant impact on attrition rates [5].
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